CONMED Corporation CNMD
$49.82
+0.69%
at last close
Analyst Consensus
- Consensus Rating
- Hold (0 Buy · 5 Hold · 1 Sell)
- Average Price Target
- $43.80
- Implied Upside
- -12.1%
- Price Target Range
- $36.00 – $52.00
- Analysts (12 mo)
- 6
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-07-30 | Piper SandlerMatt O'Brien |
Reiterates | Neutral | $39 → $45 |
| 2026-07-30 | Wells FargoLarry Biegelsen |
Maintains | Equal-weight | $39 → $46 |
| 2026-07-09 | BMO Capital |
Initiates coverage on | Market perform | $36 |
| 2026-06-29 | B of A SecuritiesTravis Steed |
Downgrades | Neutral → Underperform | $40 |
| 2026-05-18 | B of A SecuritiesTravis Steed |
Maintains | Neutral | $52 → $40 |
| 2026-05-01 | Wells FargoLarry Biegelsen |
Maintains | Equal-weight | $42 → $39 |
| 2026-03-17 | Piper SandlerMatt O'Brien |
Downgrades | Overweight → Neutral | $55 → $39 |
| 2026-01-29 | Wells FargoVik Chopra |
Maintains | Equal-weight | $41 → $42 |
| 2026-01-29 | NeedhamMike Matson |
Reiterates | Hold | — |
| 2025-12-08 | B of A SecuritiesTravis Steed |
Maintains | Neutral | $65 → $52 |
| 2025-11-06 | JP MorganRobbie Marcus |
Maintains | Neutral | $58 → $52 |
| 2025-11-06 | Piper SandlerMatt O'Brien |
Maintains | Overweight | $68 → $55 |
| 2025-11-06 | Wells FargoVik Chopra |
Maintains | Equal-weight | $57 → $47 |
| 2025-07-31 | Piper SandlerMatt O'Brien |
Maintains | Overweight | $80 → $68 |
| 2025-06-12 | NeedhamMike Matson |
Downgrades | Buy → Hold | $61 |
| 2025-05-01 | JP MorganRobbie Marcus |
Maintains | Neutral | $70 → $58 |
| 2025-05-01 | Wells FargoVik Chopra |
Maintains | Equal-weight | $70 → $57 |
| 2025-05-01 | NeedhamMike Matson |
Maintains | Buy | $91 → $61 |
| 2025-04-28 | StifelRick Wise |
Downgrades | Buy → Hold | $75 → $55 |
| 2025-02-06 | StifelRick Wise |
Maintains | Buy | $72 → $75 |
| 2025-02-06 | Wells FargoVik Chopra |
Maintains | Equal-weight | $74 → $70 |
| 2025-02-06 | NeedhamMike Matson |
Maintains | Buy | $97 → $91 |
| 2025-02-06 | JP MorganRobbie Marcus |
Downgrades | Overweight → Neutral | $85 → $70 |
| 2024-10-31 | NeedhamMike Matson |
Reiterates | Buy | $97 |
| 2024-10-04 | NeedhamMike Matson |
Reiterates | Buy | $97 |
| 2024-08-01 | Piper SandlerMatt O'Brien |
Maintains | Overweight | $95 → $80 |
| 2024-08-01 | StifelRick Wise |
Maintains | Buy | $88 → $76 |
| 2024-08-01 | Wells FargoVik Chopra |
Maintains | Equal-weight | $77 → $71 |
| 2024-08-01 | NeedhamMike Matson |
Maintains | Buy | $106 → $97 |
| 2024-07-25 | NeedhamMike Matson |
Maintains | Buy | $107 → $106 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $49.82
- Market Cap
- $1.48 billion
- 52-Week Range
- $31.44 – $56.63
- Average Volume
- 706K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.